WASHINGTON, June 24 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction.
The rule was published in the Federal Register on June 24 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.
Summary: On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4 H-benzo[ f][1, 2, 4]triazolo[4, 3- a][1, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that i...